NuriBio
PrivateLast Round
M&A
Nov 9, 2022
Est. Valuation
$21.4M
Total Funding Raised
$4.5M
Company Overview
NuriBio is a biotechnology company that develops proprietary genetic analysis tools and diagnostic kits for research and medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuriBio Comparables
Compare NuriBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenoSensor Corporation | 81% | |
| OriGene Technologies | 75% | |
| Bioneer Corporation | 71% |
NuriBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 9, 2022 | ||||
| VC Round | Aug 27, 2021 | ||||
| Series A | Jan 1, 2019 | ||||
| VC Round | Aug 9, 2018 | ||||
| Grant | Jun 1, 2018 | ||||
Accelerator | Apr 17, 2018 |
NuriBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Business Agency | Series A |
| Dadam Investment | VC Round |
| IBK Capital | Series A |
| Magna Investment | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 82% MoM.
- Nov 9, 2022
$6.08M round led by Celestra Inc.
NuriBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NuriBio's valuation, stock price, and market status.
Is NuriBio a public or private company?
NuriBio is a private company.
What is the current stock price of NuriBio?
NuriBio is a private company with no public stock price. No recent secondary market data is available.
How much is NuriBio worth (valuation)?
NuriBio's valuation is estimated at $21.1M based on funding round data.
Can I buy NuriBio stock?
NuriBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NuriBio's last funding round?
NuriBio's most recent funding round was M&A on November 10, 2022.
Who are the main investors in NuriBio?
Key investors in NuriBio include Magna Investment.
Will NuriBio IPO soon?
No public IPO plans have been announced for NuriBio.
How can I track NuriBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NuriBio's secondary market activity and sign up for updates.